FINWIRES · TerminalLIVE
FINWIRES

Hutchmed Says China Grants Priority Review for Sovleplenib in Autoimmune Hemolytic Anemia

By

-- Hutchmed (HCM) said Wednesday that China's National Medical Products Administration accepted the new drug application and granted priority review for sovleplenib to potentially treat warm antibody autoimmune hemolytic anemia.

The company said its application was supported by data from a phase 2/3 study in China. In January, the phase 3 part of the trial met its primary endpoint of durable hemoglobin response rate within weeks 5 to 24 of treatment, the company added.

The Chinese regulator also granted breakthrough therapy designation for sovleplenib in warm antibody autoimmune hemolytic anemia in March, Hutchmed said.

Price: $13.49, Change: $-0.11, Percent Change: -0.77%

Related Articles

Asia

Beijing-Shanghai High-Speed Railway's Q1 Profit Up 6%, Revenue Rises 3%

Beijing-Shanghai High-Speed Railway (SHA:601816) posted first-quarter attributable net profit of 3.14 billion yuan, up 6% from 2.96 billion yuan the previous year.Earnings per share rose to 0.0642 yuan from 0.0604 yuan, according to a Thursday filing with the Shanghai bourse.Operating revenue at the rail transportation services provider rose 3.3% year over year to 10.6 billion yuan from 10.2 billion yuan.

$SHA:601816
International

Australia's Producer Prices Rise in March Quarter

Australia's producer prices, excluding exports, increased 0.4% in the March quarter, following a 0.8% rise in the December 2025 quarter, according to data from the Australian Bureau of Statistics published Friday.The main drivers of quarterly growth were property operators, up 1% amid strong demand and rising residential rents; petroleum refining and petroleum fuel manufacturing, up over 10% due to higher oil prices; and tertiary education services, which rose 2.2% due to annual fee adjustments, the report said.Selected producer price indexes rose across key sectors, including a 2.1% increase in manufacturing driven by non-ferrous metals, a 1% rise in construction driven by house building, and an increase in education and training services due to higher export fees in higher education.On an annual basis, final demand growth rose 3% in the year to the March quarter, down from a 3.7% increase a year earlier.

$^AXJO
Asia

ASX Midday Sector Update: Materials Stocks Lead Broad Market Gains

Materials stocks were leading gainers in midday trading on Friday, with a rise of 2.4%, as all other sectors were also in the green following a strong rally in the US and a decline in the price of Brent crude.Sector heavyweights BHP Group (ASX:BHP) and Rio Tinto (ASX:RIO) both advanced around 3%.EQ Resources (ASX:EQR) fell nearly 9% after saying it will not proceed with a proposed acquisition of Tungsten Metals Group following a review of strategic priorities.

$^AXJO$ASX:BHP$ASX:EQR$ASX:RIO